Skip to main content
Erschienen in: International Urology and Nephrology 9/2022

14.02.2022 | Nephrology - Original Paper

Prognostic analysis of crescentic glomerulonephritis with acute kidney injury: a single-center cohort with 5-year follow-up

verfasst von: Zewei Chen, Jing Xu, Jun Wu, Cheng Xue, Mengna Ruan, Changlin Mei, Zhiguo Mao

Erschienen in: International Urology and Nephrology | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Crescentic glomerulonephritis (CrGN) represents a severe form of glomerular injury that results in high rates of renal failure. This study aimed to investigate the influence of potential clinical and pathological factors on renal outcomes of CrGN; and the relationship between 3-month and 5-year follow-up as well.

Methods

The cohort enrolled patients diagnosed of biopsy proven CrGN with acute kidney injury(AKI) from January 1, 2010, to January 1, 2018 in Shanghai Changzheng Hospital and followed up for 5 years.

Results

A total of 56 patients were included, among whom 11 patients (19.6%) had type I, 12 (21.4%) had type II, and 33 (58.9%) had type III CrGN. Patients with type II CrGN tended to have a lower crescent score, less renal tubular damage, and lower serum creatinine than the other two types. Three-month cumulative renal survival rates of types I, II, and III CrGN were 45.5%, 66.7%, and 48.5%, respectively. Five-year cumulative renal survival rates of types I, II, and III CrGN were 27.2%, 83.3%, and 36.4%, respectively. The Kappa Consistency Test between 3-month and 5-year outcomes was 0.573(P < 0.001). Cox regression model showed that in-hospital dialysis was an indicative renal survival factor in 3 months (HR 15.670, 95% CI 2.987–82.210, P = 0.001). It also showed that the crescent score had an unfavorable effect for renal survival in 5 years (HR 1.750 95% CI 1.018–3.009, P = 0.043).

Conclusions

Clinical manifestations and outcomes varied by different CrGN types. Three-month outcomes could partially reflect the 5-year outcomes. Severity of crescents was an independent risk factor for renal survival in CrGN.
Literatur
1.
Zurück zum Zitat Chen S et al (2016) Etiology and outcome of crescentic glomerulonephritis from a single center in China: a 10-year review. Am J Kidney Dis 67(3):376–383CrossRef Chen S et al (2016) Etiology and outcome of crescentic glomerulonephritis from a single center in China: a 10-year review. Am J Kidney Dis 67(3):376–383CrossRef
2.
Zurück zum Zitat Wu T et al (2019) Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis. Exp Ther Med 18(5):3984–3990PubMedPubMedCentral Wu T et al (2019) Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis. Exp Ther Med 18(5):3984–3990PubMedPubMedCentral
3.
Zurück zum Zitat Moroni G, Ponticelli C (2014) Rapidly progressive crescentic glomerulonephritis: early treatment is a must. Autoimmun Rev 13(7):723–729CrossRef Moroni G, Ponticelli C (2014) Rapidly progressive crescentic glomerulonephritis: early treatment is a must. Autoimmun Rev 13(7):723–729CrossRef
4.
Zurück zum Zitat Alexander S et al (2020) Crescentic glomerulonephritis: what’s different in South Asia? A single center observational cohort study. Wellcome Open Res 5:164CrossRef Alexander S et al (2020) Crescentic glomerulonephritis: what’s different in South Asia? A single center observational cohort study. Wellcome Open Res 5:164CrossRef
5.
Zurück zum Zitat Lin W et al (2010) The immunopathological spectrum of crescentic glomerulonephritis: a survey of 106 patients in a single Chinese center. Nephron Clin Pract 116(1):c65-74CrossRef Lin W et al (2010) The immunopathological spectrum of crescentic glomerulonephritis: a survey of 106 patients in a single Chinese center. Nephron Clin Pract 116(1):c65-74CrossRef
6.
Zurück zum Zitat Henique C et al (2014) Update on crescentic glomerulonephritis. Semin Immunopathol 36(4):479–490CrossRef Henique C et al (2014) Update on crescentic glomerulonephritis. Semin Immunopathol 36(4):479–490CrossRef
7.
Zurück zum Zitat Lewington AJ, Cerda J, Mehta RL (2013) Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 84(3):457–467CrossRef Lewington AJ, Cerda J, Mehta RL (2013) Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 84(3):457–467CrossRef
8.
Zurück zum Zitat Mehta RL et al (2015) International society of nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385(9987):2616–2643CrossRef Mehta RL et al (2015) International society of nephrology’s 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology. Lancet 385(9987):2616–2643CrossRef
9.
Zurück zum Zitat Macedo E, Mehta RL (2016) Renal recovery after acute kidney injury. Contrib Nephrol 187:24–35CrossRef Macedo E, Mehta RL (2016) Renal recovery after acute kidney injury. Contrib Nephrol 187:24–35CrossRef
10.
Zurück zum Zitat Chawla LS et al (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371(1):58–66CrossRef Chawla LS et al (2014) Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371(1):58–66CrossRef
11.
Zurück zum Zitat Yang L et al (2015) Acute kidney injury in China: a cross-sectional survey. The Lancet 386(10002):1465–1471CrossRef Yang L et al (2015) Acute kidney injury in China: a cross-sectional survey. The Lancet 386(10002):1465–1471CrossRef
12.
Zurück zum Zitat Alexopoulos E et al (2006) Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN). BMC Nephrol 7:16CrossRef Alexopoulos E et al (2006) Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN). BMC Nephrol 7:16CrossRef
14.
Zurück zum Zitat Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 17:204CrossRef Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1). Crit Care 17:204CrossRef
15.
Zurück zum Zitat Gameiro J et al (2018) Acute kidney injury definition and diagnosis: a narrative review. J Clin Med 7(10):307CrossRef Gameiro J et al (2018) Acute kidney injury definition and diagnosis: a narrative review. J Clin Med 7(10):307CrossRef
16.
Zurück zum Zitat Ma YC et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRef Ma YC et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944CrossRef
17.
Zurück zum Zitat Koyama A et al (2009) A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol 13(6):633–650CrossRef Koyama A et al (2009) A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol 13(6):633–650CrossRef
18.
Zurück zum Zitat Oudah N et al (2012) Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors. Clin Exp Med 12(2):121–125CrossRef Oudah N et al (2012) Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors. Clin Exp Med 12(2):121–125CrossRef
19.
Zurück zum Zitat Lim JH et al (2020) Novel histopathologic predictors for renal outcomes in crescentic glomerulonephritis. PLoS ONE 15(7):e0236051CrossRef Lim JH et al (2020) Novel histopathologic predictors for renal outcomes in crescentic glomerulonephritis. PLoS ONE 15(7):e0236051CrossRef
20.
Zurück zum Zitat Kantauskaite M, Laucyte-Cibulskiene A, Miglinas M (2018) Histopathological classification-a prognostic tool for rapidly progressive glomerulonephritis. Medicina (Kaunas) 54(2):17CrossRef Kantauskaite M, Laucyte-Cibulskiene A, Miglinas M (2018) Histopathological classification-a prognostic tool for rapidly progressive glomerulonephritis. Medicina (Kaunas) 54(2):17CrossRef
21.
Zurück zum Zitat Maliakkal JG et al (2020) Renal survival in children with glomerulonephritis with crescents: a pediatric nephrology research consortium cohort study. J Clin Med 9(8):2385CrossRef Maliakkal JG et al (2020) Renal survival in children with glomerulonephritis with crescents: a pediatric nephrology research consortium cohort study. J Clin Med 9(8):2385CrossRef
22.
Zurück zum Zitat Heilman RL et al (1987) Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis 9(2):98–107CrossRef Heilman RL et al (1987) Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. Am J Kidney Dis 9(2):98–107CrossRef
23.
Zurück zum Zitat Flossmann O et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70(3):488–494CrossRef Flossmann O et al (2011) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70(3):488–494CrossRef
24.
Zurück zum Zitat Cui Z et al (2011) Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore) 90(5):303–311CrossRef Cui Z et al (2011) Anti-glomerular basement membrane disease: outcomes of different therapeutic regimens in a large single-center Chinese cohort study. Medicine (Baltimore) 90(5):303–311CrossRef
25.
Zurück zum Zitat Wu T, Peng J, Meng T (2019) Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis. Exp Ther Med 18:3984–3990PubMedPubMedCentral Wu T, Peng J, Meng T (2019) Clinicopathological features and prognostic analysis of 49 cases with crescentic glomerulonephritis. Exp Ther Med 18:3984–3990PubMedPubMedCentral
26.
Zurück zum Zitat Gameiro J et al (2020) Acute kidney injury: from diagnosis to prevention and treatment strategies. J Clin Med 9(6):1704CrossRef Gameiro J et al (2020) Acute kidney injury: from diagnosis to prevention and treatment strategies. J Clin Med 9(6):1704CrossRef
Metadaten
Titel
Prognostic analysis of crescentic glomerulonephritis with acute kidney injury: a single-center cohort with 5-year follow-up
verfasst von
Zewei Chen
Jing Xu
Jun Wu
Cheng Xue
Mengna Ruan
Changlin Mei
Zhiguo Mao
Publikationsdatum
14.02.2022
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 9/2022
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-022-03111-w

Weitere Artikel der Ausgabe 9/2022

International Urology and Nephrology 9/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.